Bausch + Lomb (BLCO) Shares Plunge 7.33% on Weak Guidance, Recall

Bausch + Lomb (BLCO) shares plummeted 7.33% today, marking the fourth consecutive day of decline, with a total drop of 23.34% over the past four days. The share price hit a record low today, with an intraday decline of 8.34%.

Bausch + Lomb's recent stock performance can be attributed to several factors. Despite reporting a year-on-year revenue increase of 9.1% to $1.28 billion, which exceeded analysts' expectations by 1.8%, the company's full-year revenue guidance was slightly below expectations. This mixed financial performance, along with the weakest full-year guidance update among its peers, contributed to a decline in its stock price since the latest earnings report. Additionally, Bausch + Lomb announced a recall of certain EnVista intraocular lenses on April 8, 2025, which could also be impacting investor sentiment and the stock's performance.